Viewing Study NCT00605566


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-02-03 @ 5:14 PM
Study NCT ID: NCT00605566
Status: COMPLETED
Last Update Posted: 2019-02-19
First Post: 2008-01-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neuroendocrine View
None sorafenib View
None cyclophosphamide View
None pharmacodynamic View